What is Sensei Biotherapeutics Inc Annual Net Profit?

Sensei Biotherapeutics Inc Annual Net Profit rose 12.38% in the last year to $34.1 M. Its sector's average net profit growth for the last fiscal year was -32.42%.

What is Sensei Biotherapeutics Inc Price to Earning Ratio?

Sensei Biotherapeutics Inc Price to Earning Ratio is -0.33, which is negative.

What is Sensei Biotherapeutics Inc Stock Price?

Sensei Biotherapeutics Inc Stock Price fell 62.86% and underperformed its sector by 69.32% in the past year.

What is Sensei Biotherapeutics Inc Quarterly Net profit?

Sensei Biotherapeutics Inc Quarterly Net profit fell 1.81% YoY to $7.25 M. Its sector's average net profit growth YoY for the quarter was -47.39%.

What is Sensei Biotherapeutics Inc Debt to Equity Ratio?

Sensei Biotherapeutics Inc Debt to Equity Ratio of 0.1 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Sensei Biotherapeutics Inc Return on Equity(ROE)?

Sensei Biotherapeutics Inc Return on Equity(ROE) for the last financial year was -40.52%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Sensei Biotherapeutics Inc Mutual Fund Holding?

Sensei Biotherapeutics Inc Mutual Fund Holding decreased by 0.09% in the last quarter to 5.7.

What is Sensei Biotherapeutics Inc Interest Coverage Ratio?

Sensei Biotherapeutics Inc Interest Coverage Ratio is -235.81, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Sensei Biotherapeutics Inc Institutional Holding?

Sensei Biotherapeutics Inc Institutional Holding increased by 0.76% in the last quarter to 9.41.

How is the Sensei Biotherapeutics Inc today?

The Sensei Biotherapeutics Inc today is trading in the down by -23.53% at 0.39.

How has Sensei Biotherapeutics Inc performed historically?

The Sensei Biotherapeutics Inc is currently trading down -23.53% on an intraday basis in the past week the index fell -20.41%. The index has been down -22.00% in the past quarter and fell -62.86% in the past year. You can view this in the overview section.

Sensei Biotherapeutics Inc XNAS: SNSE

Sensei Biotherapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Sensei Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Sensei Biotherapeutics Inc
Rating: 1.17266675
Author: Trendlyne DVM scores

Download real time

0.39 -0.12 (-23.53%)

New 52W Low today

4.0M XNAS Volume

High vol.+loss this week

XNAS 31 Mar, 2025 4:03 PM (EDT)

Sensei Biotherapeutics Inc Key Metrics

My Metrics

Default

Market Capitalization Low in industry Unavailable in chosen country	9.8
PE TTM Negative PE TTM Unavailable in chosen country	-0.3
Price to Book Low in industry Unavailable in chosen country	0.2
Institutional holding current Qtr % Low in industry Unavailable in chosen country	9.4
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-1.8
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	23.4
Piotroski Score Low in industry Unavailable in chosen country	1
Rel Perf vs Sector quarter% Unavailable in chosen country	-29
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-40.5
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-35.4

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

15.2 / 100

Technically Bearish

31.7 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Sensei Biotherapeutics Inc Stock Price Analysis

Day Price Range -23.5% 1 Day return Unavailable in chosen country	0.4 (LTP) 0.20.5 LowHigh
Week Price Range -20.4% 1 Week return Unavailable in chosen country	0.4 (LTP) 0.20.8 LowHigh
Month Price Range -11.4% 1 Month return Unavailable in chosen country	0.4 (LTP) 0.20.8 LowHigh
52 Week Price Range -62.9% 1 Year return Unavailable in chosen country	0.4 (LTP) 0.21.9 LowHigh

View full Share Price History

Sensei Biotherapeutics Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Sensei Biotherapeutics Inc Stock Analysis

Sensei Biotherapeutics Inc stock analysis with key metrics, changes, and trends.

Sensei Biotherapeutics Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$34.1 M	12.38%	positive	Annual Net Profit rose 12.38% in the last year to $34.1 M. Its sector's average net profit growth for the last fiscal year was -32.42%.
Price to Earning Ratio	-0.33	-	negative	Price to Earning Ratio is -0.33, which is negative.
Stock Price	$0.39	-62.86%	negative	Stock Price fell 62.86% and underperformed its sector by 69.32% in the past year.
Quarterly Net profit	$7.25 M	1.81%	negative	Quarterly Net profit fell 1.81% YoY to $7.25 M. Its sector's average net profit growth YoY for the quarter was -47.39%.
Debt to Equity Ratio	0.1	-	positive	Debt to Equity Ratio of 0.1 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-40.52 %	-40.52%	negative	Return on Equity(ROE) for the last financial year was -40.52%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	5.70 %	-0.09%	negative	Mutual Fund Holding decreased by 0.09% in the last quarter to 5.7.
Interest Coverage Ratio	-235.81	-	negative	Interest Coverage Ratio is -235.81, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	9.41 %	0.76%	positive	Institutional Holding increased by 0.76% in the last quarter to 9.41.

VIEW LESS

Loading data..

Sensei Biotherapeutics Inc - Company Profile

What does Sensei Biotherapeutics Inc do?

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

Sensei Biotherapeutics Inc Management structure

All Gross Remunerations are in USD

Ms. Erin Colgan

Chief Financial Officer and Principal Accounting Officer

2024

Gross Remuneration

Year

Mr. Josiah Craver

Senior Vice President, Finance, Principal financial officer and principal accounting officer

2024

Gross Remuneration

Year

Mr. David Gaiero

Interim Principal financial officer and Interim Principal accounting officer

2024

Gross Remuneration

Year

Sensei Biotherapeutics Inc Board of directors

All Gross Remunerations are in USD

Dr. Samuel Broder,M.D.

Independent Director

2024

Gross Remuneration

Year

Dr. Jessie M. English, PhD

Independent Director

2024

Gross Remuneration

Year

Dr. Deneen Vojta, M.D.

Independent Director

2024

Gross Remuneration

Year

Sensei Biotherapeutics Inc Live Share Price Today, Share Analysis and Chart

New 52W Low today

High vol.+loss this week

Sensei Biotherapeutics Inc Key Metrics

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Sensei Biotherapeutics Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Sensei Biotherapeutics Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Sensei Biotherapeutics Inc Stock Analysis

Sensei Biotherapeutics Inc stock analysis with key metrics, changes, and trends.

Annual Net Profit rose 12.38% in the last year to $34.1 M. Its sector's average net profit growth for the last fiscal year was -32.42%.

Price to Earning Ratio is -0.33, which is negative.

Stock Price fell 62.86% and underperformed its sector by 69.32% in the past year.

Quarterly Net profit fell 1.81% YoY to $7.25 M. Its sector's average net profit growth YoY for the quarter was -47.39%.

Debt to Equity Ratio of 0.1 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -40.52%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 0.09% in the last quarter to 5.7.

Interest Coverage Ratio is -235.81, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding increased by 0.76% in the last quarter to 9.41.

Sensei Biotherapeutics Inc - Company Profile

What does Sensei Biotherapeutics Inc do?

Sensei Biotherapeutics Inc Management structure

Ms. Erin Colgan

Chief Financial Officer and Principal Accounting Officer

Mr. Josiah Craver

Senior Vice President, Finance, Principal financial officer and principal accounting officer

Mr. David Gaiero

Interim Principal financial officer and Interim Principal accounting officer

Sensei Biotherapeutics Inc Board of directors

Dr. Samuel Broder,M.D.

Independent Director

Dr. Jessie M. English, PhD

Independent Director

Dr. Deneen Vojta, M.D.

Independent Director

Sensei Biotherapeutics Inc FAQ

How is Sensei Biotherapeutics Inc today?

Sensei Biotherapeutics Inc today is trading in the red, and is down by -23.53% at 0.39.

How has Sensei Biotherapeutics Inc performed historically?

Sensei Biotherapeutics Inc is currently trading down -23.53% on an intraday basis. In the past week the stock fell -20.41%. stock has been down -22.00% in the past quarter and fell -62.86% in the past year. You can view this in the overview section.